(Q38246942)

1 September 2017

1 reference

title

Septic shock: the cardiovascular abnormality and therapy (English)

1 reference

cardiovascular abnormality

1 September 2017

0 references

1 reference

1 reference

Natanson C

1

1 reference

1 September 2017

Hoffman WD

series ordinal

2

1 reference

1 September 2017

Parrillo JE

series ordinal

3

1 reference

1 September 2017

publication date

1 April 1989

1 reference

Journal of Cardiothoracic and Vascular Anesthesia

1 September 2017

published in

1 reference

1 September 2017

volume

3

1 reference

1 September 2017

issue

2

1 reference

1 September 2017

page(s)

215-227

1 reference

Left ventricular performance in septic shock: reversible segmental and global abnormalities.

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Profound but reversible myocardial depression in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Hemodynamic and metabolic studies on shock associated with gram negative bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

HEMODYNAMIC AND METABOLIC STUDIES ON SHOCK ASSOCIATED WITH BACTEREMIA. OBSERVATIONS ON 16 PATIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Circulating factors in the etiology of pulmonary insufficiency and right heart failure accompanying severe sepsis (peritonitis)

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Cardiopulmonary effects of volume loading in patients in septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Patterns Of Septic Shock In Man—a Detailed Study Of 56 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Myocardial depression during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

The systemic septic response: does the organism matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Hemodynamic studies and results of therapy in 50 patients with bacteremic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Right ventricular performance in septic shock: a combined radionuclide and hemodynamic study

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

The coronary circulation in human septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

On the absorption of bacterial endotoxin from the gastro-intestinal tract of the normal and shocked animal

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Intestinal endotoxemia. Clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Cachectin and tumour necrosis factor as two sides of the same biological coin

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Shock and tissue injury induced by recombinant human cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Changes in the blood coagulation system associated with septicemia

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Plasma Kallikrein and Hageman Factor in Gram-Negative Bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Endotoxin, prekallikrein, complement and systemic vascular resistance. Sequential measurements in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Activation of the properdin pathway of complement in patients with gram-negative of bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Prostaglandins and the hemodynamic course of endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

1 reference

7 January 2021

Left ventricular function and tissue hypoxia in irreversible hemorrhagic and endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Effects of endotoxin on myocardial hemodynamics, performance, and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Myocardial function in shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Effects of coronary hypotension and endotoxin on myocardial performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Hypotension (shock) in dogs produced by Escherichia coli endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Effects of E. coli endotoxemia on ventricular performance

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

The enzymatic synthesis of lipid A: molecular structure and biologic function of monosaccharide precursors.

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Protection of mice against lethal endotoxemia by a lipid A precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Gram-Negative Rod Bacteremia: Microbiologic, Immunologic, and Therapeutic Considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Protective antibody to endotoxin core: the emperor's new clothes?

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Ibuprofen in canine endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

On-site physician staffing in a community hospital intensive care unit. Impact on test and procedure use and on patient outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

Newer catecholamines for treatment of heart failure and shock: An update on dopamine and a first look at dobutamine

1 reference

https://api.crossref.org/works/10.1016%2FS0888-6296%2889%2993026-3

7 January 2021

10.1016/S0888-6296(89)93026-3

Identifiers

DOI

1 reference

1 September 2017

1 reference